4:18pm: CPI report in focus
US stocks finished the session mixed ahead of key inflation data due to be released on Tuesday and as President Trump reportedly granted another 90-day extension on some China tariffs.
The Dow Jones fell 0.5% to 43,975 points while the S&P 500 was down 0.3% at 6,373 points. The Nasdaq pared earlier gains to finish the day down 0.3% at 21,385 points.
3:30pm: Proactive news headlines
- Tiziana Life Sciences Ltd received FDA approval for a Phase 2a trial of intranasal foralumab in Multiple System Atrophy patients.
- American Resources Corp said its ReElement Technologies unit has developed commercial protocols to produce 99.9%-plus pure germanium from recycled and ore-based feedstocks.
- Royalty Management Holding Corp reported record second-quarter results, with first-half 2025 revenue up 440% to $2.25 million on gains from resource and technology investments.
- Wedgemount Resources Corp agreed to sell up to a 5% overriding royalty interest in its Texas oil and gas assets for as much as $800,000.
- Falcon Oil & Gas Ltd reported one of the best results to date in Australia’s Beetaloo Basin, with a well averaging 6.7 million cubic feet of gas per day over 90 days.
- EDM Resources Inc said a study on Scotia Mine samples indicates the potential to raise metal grades and cut processing costs through dense media separation.
- BioHarvest Sciences Inc. saw second-quarter revenue rise 41% to $8.5 million, driven by growth in its VINIA line and CDMO business.
- Santacruz Silver Mining Ltd said its Bolivian unit raised $10.1 million via a second promissory note issuance, bringing total program proceeds to $20.2 million.
- Gunnison Copper Corp began operations at its Johnson Camp Mine plant in Arizona, with first copper sales expected by September.
- Spanish Mountain Gold Ltd increased its planned fundraising to C$6 million following strong investor demand for its share offering.
- Caledonia Mining Corporation PLC reported record second-quarter production, profitability, and cash flow at its Blanket Mine, surpassing full-year profit levels from recent years.
3:00pm: Intel CEO to meet with Trump
Intel Corp (NASDAQ:INTC, ETR:INL) shares added more than 5% on reports its CEO Lip-Bu Tan’s scheduled visit to the White House, following a public call from President Donald Trump demanding Tan’s resignation.
According to a report by the Wall Street Journal citing unnamed sources, Tan is set to meet with Trump on Monday to discuss his personal and professional background and to explore potential areas for collaboration between Intel and the US government.
Tan became Intel’s CEO in March 2025, and during his tenure the company has faced challenges related to its manufacturing business, market share, and AI strategy.
Intel has not commented on the reported meeting.
Shares of Intel traded 5.3% higher at $21 in the early afternoon on Monday.
2:25pm: Stocks on the move
- Royalty Management Holding Corp reported record second-quarter results, with first-half 2025 revenue rising 440% year-over-year to $2.25 million on strong resource and technology investments.
- Intel Corp shares jumped over 5% on reports CEO Lip-Bu Tan will meet with President Donald Trump at the White House to discuss his background and potential collaboration.
- Monday.com shares plunged nearly 27% after issuing Q3 revenue guidance slightly below analyst expectations despite beating Q2 earnings estimates.
- Barrick Gold Corp. posted strong Q2 earnings as gold output rose 5% and copper production surged 34% sequentially, with copper output up 37% year-over-year.
- Tiziana Life Sciences Ltd received FDA approval for a Phase 2a trial of intranasal foralumab in Multiple System Atrophy patients.
- American Resources Corp said its ReElement Technologies unit developed protocols to produce germanium with over 99.9% purity from recycled and ore-based sources.
- Micron Technology Inc raised its fiscal Q4 2025 revenue forecast to about $11.2 billion, citing stronger DRAM pricing and solid execution.
- Versarien PLC shares fell 31% after announcing plans to place key subsidiaries into administration or liquidation to preserve cash.
- GSK PLC gained after the FDA accepted gepotidacin for priority review as an oral treatment for gonorrhoea, with a decision expected by December 2025.
1:00pm: Dow dips slightly
Wall Street is trading mixed so far today as investors digest last week’s record-setting momentum.
The Nasdaq edged up 0.2%, extending gains following two consecutive record closes last week. The S&P 500 added 0.1%, and the Dow Jones slipped 0.3%, weighed down by some rotation out of cyclical sectors.
In Washington, President Trump weighed in on the recent Nvidia export deal with China, stating the agreement only covers the older H20 chip, which he labeled “obsolete.” Trump added he would not approve exports of Nvidia’s newest Blackwell chip unless it undergoes significant downgrades.
Nvidia CEO Jensen Huang is expected to visit this week to discuss the new chip and potential export issues.
From an earnings perspective, Raymond James calls this one of the strongest and broadest seasons since 2021. Eight out of 11 sectors have seen positive earnings per share (EPS) revisions, with only health care, energy, and materials recording downward adjustments. However, equity performance remains unusually narrow. There are 13% more stocks down 10% or more than up by the same margin, Raymond James noted, marking the largest negative skew since early 2022.
Raymond James also points out that EPS growth outside the “Magnificent 7” tech giants continues to be delayed, and free cash flow relative to net income remains subdued due to elevated capital expenditures (capex) on artificial intelligence. Capex outside of AI has been revised higher but still holds a modest positive outlook.
12:05pm: Strong earnings boost stocks
Q2 earnings have delivered a strong performance, marking the third consecutive quarter of double-digit earnings growth and reinforcing investor confidence in the market’s rally this year, noted XTB's research director Kathleen Brooks.
:The news is good for the US, it is reporting double digit earnings growth for the third consecutive quarter, which helps to justify the strong performance for US stocks in the second half of this year," Brooks said.
Tech heavyweight Palantir notably drove momentum with a 48% increase in revenue compared to the previous year, lifting its market capitalization to $448 billion, a $270 billion rise since April. While its forward price-to-earnings ratio exceeds 250, raising concerns among some investors, Palantir supporters argue that the valuation is justified by the company’s strong contract pipeline, including a recent $10 billion deal with the US Department of Defense.
“It is hard to call a peak in tech stocks,” said Brooks.
11:15am: Nvidia-AMD deal 'destabilizing' to markets
Nvidia and AMD’s agreement to give the US government 15% of their China AI chip revenues in exchange for export licenses raises concerns about the future of global trade, according to Nigel Green, CEO of deVere Group.
Green said the move risks recasting export controls as financial transactions, undermining their original purpose. “Export controls are meant to protect national security, not to serve as revenue-sharing schemes. The moment you convert them into commission deals, you change their purpose entirely – and send a destabilizing message to global markets.”
Green warned that the 15% revenue-sharing deal could set a precedent for other governments to charge companies for export permissions, potentially leading to a fragmented global trade environment. “If the US, the world’s largest economy, can charge companies for permission to export, other governments will take note,” he said. “We could quickly see an environment where market access is auctioned off, dictated by political leverage rather than clear, consistent rules.”
10:35am: CPI on deck
This week, Wall Street will be paying close attention to a busy schedule that includes new US inflation reports, updates on US-Russia relations, and a steady stream of company earnings.
The US consumer price index (CPI) and producer price index (PPI) reports, due Tuesday and Thursday respectively, will be critical in assessing the impact of tariffs imposed by President Trump and their ripple effects on inflation.
“We expect the headline CPI to rise 0.2% month-on-month with the annual rate inching up to 2.8%,” said Michael Brown, senior research strategist at Pepperstone. “Focus will fall heavily on core goods prices, which rose to near two-year highs last time out, as participants and policymakers alike continue to gauge tariff passthrough.
“A hot print here would cast further doubt on the potential for a September rate cut, which markets currently assign around a 90% chance. That, to me, seems far too high.”
9:50am: Investors eye inflation
Wall Street was treading lightly at Monday’s open, with stocks inching higher.
The Dow Jones was little changed, up 8 points to 44,184, while the S&P 500 added 5 points to 6,394. The Nasdaq gained 12 points to 21,462, and the Russell 2000 rose 7 points to 2,222.
Energy prices continued to slide, giving inflation watchers something to cheer about. “Falling energy prices should help keep inflation in check, and that’s important for those expecting the Federal Reserve to cut interest rates as early as next month,” said Ipek Ozkardeskaya, senior analyst at Swissquote Bank. She added that any disappointment on the Ukraine front could quickly reverse oil’s latest drop, but for now, “ample supply and a cloudy demand outlook support the bearish camp.”
In Washington, eyes are on Intel CEO Lip-Bu Tan, who will meet with President Trump at the White House later today after Trump called for his removal last week over alleged China ties. Tan is expected to outline his personal background, emphasize Intel’s role in US national security, and push for cooperation.
Big sports media news also hit: Paramount (PARA) will pay $7.7 billion for exclusive US rights to UFC events starting in 2026, replacing ESPN’s $500 million-a-year deal. The seven-year agreement will include all fights in the Paramount+ subscription, with no extra pay-per-view charges.
Meanwhile, Goldman Sachs warned that US consumers could bear the brunt of Trump’s latest tariffs. Households, which currently absorb about 22% of tariff costs, could see that figure jump to 67%, with Goldman projecting core PCE inflation to end the year at 3.2% instead of 2.4% without the tariff effects.
In commodities, China’s CATL confirmed it has suspended production at its Jianxiawo lithium mine for at least three months due to permit issues — a site that accounts for 2 to 3% of global supply.
Chip stocks were also in focus after the Financial Times reported that Nvidia (NVDA) and AMD (AMD) will pay 15% of their Chinese chip sales to the US government in an unusual bid to ease export restrictions. TSMC shares, viewed as a proxy for sentiment, climbed more than 1% in early trading.
The main event for markets this week will be Wednesday’s US CPI release, where both headline and core readings are expected to rise. In Ozkardeskaya’s words, “In normal times, sticky inflation near 3% would justify a ‘no cut’ from the Fed next month — but these are not normal times.”
8:30am: Calm futures
US stock futures were calm Monday morning as investors set their sights on another possible round of record highs.
The Dow futures rose about 0.3%, S&P 500 futures added 0.1%, and Nasdaq futures hovered near the flatline.
Last week ended on a high note for tech. The Nasdaq notched back-to-back records, while the S&P 500 came within a whisker of one. Apple enjoyed its best week since 2020 after a White House cameo with President Trump, and Nvidia finished Friday at yet another record amid signs Big Tech might dodge looming chip tariffs.
But over the weekend, an eyebrow-raising twist emerged: reports say Nvidia and AMD have struck a deal to hand over 15% of revenue from certain chip sales to China directly to the US government. The goal? Reduce the risk of tougher export restrictions. Market reaction so far has been muted: Nvidia shares are down 0.7% premarket and AMD off about 1%, though Taiwan’s TSMC, often a bellwether for chip sentiment, is up more than 1%.
Beyond chip drama, traders have a big economic week ahead. The Consumer Price Index (CPI) lands Tuesday, followed by the Producer Price Index Thursday and retail sales Friday. Inflation picked up in June, and with tariffs working their way into prices, economists expect more stickiness especially in core inflation, still parked near 3%, above the Fed’s 2% target.
Lower oil prices could provide some relief. Crude has been under pressure, recently slipping below key technical levels to settle in a medium-term bearish zone. Gold is also down as traders await fresh signals on US tariffs and watch developments in Ukraine.
Still, the inflation numbers could be pivotal. A hot print might cool September rate-cut hopes and push bond yields higher. A soft reading could embolden the dovish camp — though some investors may remain skeptical after the recent firing of the Bureau of Labor Statistics chief over data revisions.